Literature DB >> 28635380

Inorganic nanoparticles as potential regulators of immune response in dendritic cells.

Silvia Fogli1, Costanza Montis1, Sara Paccosi2, Angela Silvano3, Elena Michelucci4, Debora Berti1, Alberto Bosi3, Astrid Parenti2, Paolo Romagnoli3.   

Abstract

AIM: The spontaneous adsorption of proteins on nanoparticles (NPs) in biological media is exploited to prepare complexes of NPs and proteins from cancer cells' lysates for application in cancer immunotherapy. MATERIALS &
METHODS: Gold (Au) and silica NPs were synthesized, incubated with cancer cells' lysates and characterized. Dendritic cells (DCs) were challenged with protein-coated NPs, their maturation, viability and morphology were evaluated and lymphocytes T proliferation was determined.
RESULTS: Silica and Au NPs bound different pools of biomolecules from lysates, and are therefore promising selective carriers for antigens. When incubated with immature DCs, NPs were efficiently endocytosed without cytotoxicity. Finally, protein-coated AuNPs promoted DC maturation and DC-mediated lymphocyte proliferation, at variance with lysate alone and protein-coated silica NPs, that did not promote DCs maturation.
CONCLUSION: These results demonstrate that the spontaneous formation of protein coronas on NPs represents a possible approach to fast, easy, cost-effective DCs stimulation.

Entities:  

Keywords:  cancer immunotherapy; dendritic cells; lysate; nanoparticles; protein corona

Mesh:

Substances:

Year:  2017        PMID: 28635380     DOI: 10.2217/nnm-2017-0061

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  9 in total

1.  Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits.

Authors:  Michael-Joseph Gorbet; Akansha Singh; Chenkai Mao; Steven Fiering; Ashish Ranjan
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

2.  Dietary Nanoparticles Interact with Gluten Peptides and Alter the Intestinal Homeostasis Increasing the Risk of Celiac Disease.

Authors:  Clara Mancuso; Francesca Re; Ilaria Rivolta; Luca Elli; Elisa Gnodi; Jean-François Beaulieu; Donatella Barisani
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

Review 3.  Bioactive Nanoparticles for Cancer Immunotherapy.

Authors:  Suchithra Poilil Surendran; Myeong Ju Moon; Rayoung Park; Yong Yeon Jeong
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

Review 4.  DNA Vaccines-How Far From Clinical Use?

Authors:  Dominika Hobernik; Matthias Bros
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

5.  Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.

Authors:  Javier I Sanchez-Villamil; Daniel Tapia; Alfredo G Torres
Journal:  mBio       Date:  2019-08-13       Impact factor: 7.867

Review 6.  Nanomaterials for modulating innate immune cells in cancer immunotherapy.

Authors:  Quoc-Viet Le; Geon Yang; Yina Wu; Ho Won Jang; Mohammadreza Shokouhimehr; Yu-Kyoung Oh
Journal:  Asian J Pharm Sci       Date:  2018-08-23       Impact factor: 6.598

Review 7.  ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.

Authors:  Miguel Hueso; Adrián Mallén; Marc Suñé-Pou; Josep M Aran; Josep M Suñé-Negre; Estanislao Navarro
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 8.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

9.  Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs.

Authors:  Yan Li; Xin Chen; Ronghua Jin; Lu Chen; Ming Dang; Hao Cao; Yun Dong; Bolei Cai; Guo Bai; J Justin Gooding; Shiyu Liu; Duohong Zou; Zhiyuan Zhang; Chi Yang
Journal:  Sci Adv       Date:  2021-02-24       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.